Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity

Journal of Pathology

Volumn 226, Issue 4, 2012, Pages 666-673

  Sun, Xiaodong ^a   Li, Dengwen ^a   Yang, Yunfan ^a   Ren, Yuan ^a   Li, Jingyu ^a   Wang, Zaizhu ^a   Dong, Bin ^a   Liu, Min ^b   Zhou, Jun ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

breast cancer; CLIP 170; microtubule; paclitaxel; sensitivity

Indexed keywords

BETA ACTIN; CASPASE 3; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MICROTUBULE PROTEIN; PACLITAXEL; PROTEIN CLIP 170; TUBULIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MICROTUBULE ASSEMBLY; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEDIMENTATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; PACLITAXEL;

EID: 84862776774     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3026     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Rowinsky EK,. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 1997; 48: 353-374. (Pubitemid 27101837)
3. Jordan MA, Wilson L,. Microtubules as a target for anticancer drugs. Nature Rev Cancer 2004; 4: 253-265. (Pubitemid 38525281)
4. Zhou J, Giannakakou P,. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anti-Cancer Agents 2005; 5: 65-71. (Pubitemid 40081295)
5. Orr GA, Verdier-Pinard P, McDaid H, et al., Mechanisms of Taxol resistance related to microtubules. Oncogene 2003; 22: 7280-7295. (Pubitemid 37487160)
6. Rouzier R, Rajan R, Wagner P, et al., Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci U S A 2005; 102: 8315-8320. (Pubitemid 40800086)
7. Wang H, Liu B, Zhang C, et al., Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol 2009; 218: 76-85.
8. Alli E, Bash-Babula J, Yang JM, et al., Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002; 62: 6864-6869. (Pubitemid 35424074)
9. Bhat KM, Setaluri V,. Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 2007; 13: 2849-2854. (Pubitemid 46849557)
10. Perez F, Diamantopoulos GS, Stalder R, et al., CLIP-170 highlights growing microtubule ends in vivo. Cell 1999; 96: 517-527. (Pubitemid 29106839)
11. Slep KC,. Structural and mechanistic insights into microtubule end-binding proteins. Curr Opin Cell Biol 2010; 22: 88-95.
12. Komarova YA, Akhmanova AS, Kojima S, et al., Cytoplasmic linker proteins promote microtubule rescue in vivo. J Cell Biol 2002; 159: 589-599.
13. Galjart N,. CLIPs and CLASPs and cellular dynamics. Nature Rev Mol Cell Biol 2005; 6: 487-498. (Pubitemid 40780560)
14. Pierre P, Pepperkok R, Kreis TE,. Molecular characterization of two functional domains of CLIP-170 in vivo. J Cell Sci 1994; 107: 1909-1920. (Pubitemid 24226441)
15. Vichai V, Kirtikara K,. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols 2006; 1: 1112-1116.
16. Huo L, Li D, Sun L, et al., Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes. J Pathol 2011; 223: 28-36.
17. Gao J, Huo L, Sun X, et al., The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration. J Biol Chem 2008; 283: 8802-8809.
18. Brooks SC, Locke ER, Soule HD,. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 1973; 248: 6251-6253.
19. Jordan MA, Wilson L,. The use and action of drugs in analyzing mitosis. Methods Cell Biol 1999; 61: 267-295.
20. O'Brien MA, Daily WJ, Hesselberth PE, et al., Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen 2005; 10: 137-148.
21. Tanenbaum ME, Galjart N, van Vugt MA, et al., CLIP-170 facilitates the formation of kinetochore-microtubule attachments. EMBO J 2006; 25: 45-57. (Pubitemid 43077294)
22. Nakano A, Kato H, Watanabe T, et al., AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nature Cell Biol 2010; 12: 583-590.
23. Miller RK, D'Silva S, Moore JK, et al., The CLIP-170 orthologue Bik1p and positioning the mitotic spindle in yeast. Curr Top Dev Biol 2006; 76: 49-87. (Pubitemid 44760538)
24. Suzuki K, Takahashi K,. Regulation of lamellipodia formation and cell invasion by CLIP-170 in invasive human breast cancer cells. Biochem Biophys Res Commun 2008; 368: 199-204.